elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30244827-B4F28A50-B496-481D-9C60-374C0E43E75D
Q30244827-B4F28A50-B496-481D-9C60-374C0E43E75D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30244827-B4F28A50-B496-481D-9C60-374C0E43E75D
Pharmacodynamic and pharmacokinetic evaluation of insulin glargine U300 for the treatment of type 1 diabetes.
P2860
Q30244827-B4F28A50-B496-481D-9C60-374C0E43E75D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30244827-B4F28A50-B496-481D-9C60-374C0E43E75D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0792057a116b55faa4a56c623036cf8ccf07815d
P2860
New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).